Position in ZTS
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$5,559,592
-$33,897,251 QoQ
Shares Held
77,367
-76.8% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#324
of 1,412 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Carnegie Investment Counsel holds $5,774,820 across 2 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (96.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
77,367 | $5,559,592 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
2,600 | $215,228 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,559,592 | 77,367 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $39,456,843 | 333,786 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $38,310,805 | 304,489 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $49,826,642 | 340,532 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $49,743,215 | 318,969 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $24,437,353 | 148,420 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $25,245,188 | 154,945 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $30,591,818 | 156,576 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $27,317,548 | 157,577 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $30,439,694 | 179,893 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $34,354,222 | 174,060 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $30,017,291 | 172,533 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $28,585,654 | 165,993 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $27,147,196 | 163,105 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $23,494,749 | 160,319 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $23,029,288 | 155,299 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $27,149,853 | 157,949 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $30,678,689 | 162,674 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $39,586,302 | 162,219 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $31,486,401 | 162,184 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $30,514,586 | 163,740 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $26,572,072 | 168,733 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $27,330,835 | 165,141 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $26,428,771 | 159,816 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $21,257,096 | 155,116 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $18,284,436 | 155,361 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||